Reimbursement-First Thinking in Early-Stage Diagnostics with OraLiva
In this episode of Diagnosing Dx, I’m joined by Spencer Price, Chief Executive Officer at OraLiva, a company building an AI-powered precision diagnostic designed to transform oral cancer detection and shift the standard of care.
We explore Spencer’s unconventional move from autonomous vehicles into diagnostics, why OraLiva built commercialisation and reimbursement strategy into the company from day one, and what it really takes to turn breakthrough science into a product that fits seamlessly into clinical workflows. Spencer shares how understanding the healthcare landscape early can shape…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.